BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Clinical Outcome
6 results:

  • 1. Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
    Trentini F; Mazzaschi G; Milanese G; Pavone C; Madeddu D; Gnetti L; Frati C; Lorusso B; Lagrasta CAM; Minari R; Ampollini L; Ledda RE; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
    Tumori; 2022 Feb; 108(1):86-92. PubMed ID: 33730957
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
    Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
    Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
    Liu Y; Chen L; Zhang R; Chen B; Xiang Y; Zhang M; Huang X; Zhang W; Chen X; Pan T; Yan L; Jin T; Liu S; Feng J; Duan T; Xie T; Lin S; Sui X
    Medicine (Baltimore); 2020 Mar; 99(11):e19481. PubMed ID: 32176081
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer.
    Jiang W; Wang L; Zhang J; Shen H; Dong W; Zhang T; Li X; Wang K; Du J
    Medicine (Baltimore); 2018 Sep; 97(39):e12442. PubMed ID: 30278522
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.
    Jiang W; Bi N; Zhang WJ; Wu LH; Liu LP; Men Y; Wang JB; Liang J; Hui ZG; Zhou ZM; Wang LH
    Oncotarget; 2016 Apr; 7(16):22632-8. PubMed ID: 26988918
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.
    Pirker R; Pereira JR; von Pawel J; Krzakowski M; Ramlau R; Park K; de Marinis F; Eberhardt WE; Paz-Ares L; Störkel S; Schumacher KM; von Heydebreck A; Celik I; O'Byrne KJ
    Lancet Oncol; 2012 Jan; 13(1):33-42. PubMed ID: 22056021
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.